TRIMERIC S1-CD40L FUSION PROTEIN VACCINE AGAINST MIDDLE EAST RESPIRATORY SYNDROME-CORONAVIRUS

• 收藏
• 分享

专利权人:

King Abdulaziz University

发明人:

Anwar M. Hashem

申请号：

US16201409

公开号：

US20200164058A1

申请日:

2018.11.27

申请国别(地区):

US

年份:

2020

代理人:

摘要：

An immunogenic CD40-targeted trimeric MERS-CoV S1 fusion polypeptide as well as a corresponding polynucleotide encoding it and its use for safely inducing immune responses directed against MERS-CoV without inducing vaccine associated respiratory pathologies associated with non-targeted vaccines.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/